EX-4.2
from S-4
4 pages
Supplemental Indenture (This “Supplemental Indenture”), Dated as of September 28, 2012 Among Par Pharmaceutical Companies, Inc., a Delaware Corporation (The “Issuer”), the Guarantors and Wells Fargo Bank, National Association, a National Banking Association, as Trustee (The “Trustee”)
12/34/56
EX-4.1
from S-4
141 pages
Indenture Dated as of September 28, 2012 Between Sky Growth Acquisition Corporation, to Be Merged With and Into Par Pharmaceutical Companies, Inc., and Wells Fargo Bank, National Association, as Trustee 7 3/8% Senior Notes Due 2020
12/34/56